An international study led by Dana-Farber Cancer Institute has shown that a new type of gene therapy may help boys with a fatal immune disorder commonly known as “bubble boy” disease. Sung-Yun Pai, HMS assistant professor of pediatrics at the Dana-Farber Cancer Institute, presented the study’s findings at the annual meeting of the American Society of Hematology.
